Cynata Therapeutics Limited
CYYNF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $27,419 | $56,576 | $51,235 | $18,981 |
| - Cash | $5,050 | $10,508 | $6,205 | $11,167 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $22,369 | $46,068 | $45,029 | $7,814 |
| Revenue | -$85 | $1,970 | -$230 | $2,546 |
| % Growth | -104.3% | 956.3% | -109% | – |
| Gross Profit | -$85 | $1,970 | -$230 | $1,132 |
| % Margin | 100% | 100% | 100% | 44.5% |
| EBITDA | -$5,815 | -$3,513 | -$5,549 | -$6,946 |
| % Margin | 6,842.2% | -178.3% | 2,411.9% | -272.9% |
| Net Income | -$5,741 | -$3,650 | -$5,204 | -$4,541 |
| % Margin | 6,755.1% | -185.3% | 2,261.8% | -178.4% |
| EPS Diluted | -0.025 | -0.02 | -0.029 | -0.025 |
| % Growth | -28.3% | 31.7% | -14.6% | – |
| Operating Cash Flow | -$5,795 | -$2,925 | -$5,108 | -$4,853 |
| Capital Expenditures | $50 | -$50 | $0 | $0 |
| Free Cash Flow | -$5,745 | -$2,975 | -$5,108 | -$4,853 |